Compile Data Set for Download or QSAR
maximum 50k data
Found 7 Enz. Inhib. hit(s) with Target = 'Isoform 2 of Vascular endothelial growth factor receptor 3 (Short) 98-1298]'
TargetIsoform 2 of Vascular endothelial growth factor receptor 3 (Short) 98-1298](Homo sapiens (Human))
Cancer Therapeutics Crc

US Patent
LigandPNGBDBM176599(US9120761, 13)
Affinity DataIC50:  205nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsoform 2 of Vascular endothelial growth factor receptor 3 (Short) 98-1298](Homo sapiens (Human))
Cancer Therapeutics Crc

US Patent
LigandPNGBDBM176589(US9120761, 3)
Affinity DataIC50:  538nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsoform 2 of Vascular endothelial growth factor receptor 3 (Short) 98-1298](Homo sapiens (Human))
Cancer Therapeutics Crc

US Patent
LigandPNGBDBM176595(US9120761, 9)
Affinity DataIC50:  1.01E+3nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsoform 2 of Vascular endothelial growth factor receptor 3 (Short) 98-1298](Homo sapiens (Human))
Cancer Therapeutics Crc

US Patent
LigandPNGBDBM176594(US9120761, 8)
Affinity DataIC50:  1.18E+3nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsoform 2 of Vascular endothelial growth factor receptor 3 (Short) 98-1298](Homo sapiens (Human))
Cancer Therapeutics Crc

US Patent
LigandPNGBDBM176592(US9120761, 6)
Affinity DataIC50:  1.04E+4nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsoform 2 of Vascular endothelial growth factor receptor 3 (Short) 98-1298](Homo sapiens (Human))
Cancer Therapeutics Crc

US Patent
LigandPNGBDBM176597(US9120761, 11)
Affinity DataIC50:  5.98E+4nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIsoform 2 of Vascular endothelial growth factor receptor 3 (Short) 98-1298](Homo sapiens (Human))
Cancer Therapeutics Crc

US Patent
LigandPNGBDBM176596(US9120761, 10)
Affinity DataIC50: >6.60E+4nMpH: 7.4Assay Description:Compounds of the invention may be tested for in vitro activity in the following assay: A biotin labeled peptide is used as substrate (amino acid sequ...More data for this Ligand-Target Pair
In DepthDetails US Patent